Outcome of Board Meeting for the half year ended 30th September 2026

Date: 29th October, 2026 The Manager, BSE SME Platform Department of Corporate Services 25th Floor, P.J. Towers, Dalal Street, Fort, Mumbai - 400 001 BSE Scrip Code: 544013 Reference: Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) Sub: Outcome of Board Meeting under Regulation 30 of SEBI (LODR) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulations 30 and 33 read with Schedule III and other applicable provisions of the SEBI Listing Regulations, we hereby inform you that the Board of Directors of the Company at their meeting held today i.e., October 29, 2026, has, inter alia, approved Unaudited Financial Results of the Company for the Half year ended September 30, 2026, as per recommendation by the Audit Committee. Accordingly, we are enclosing herewith the following: 1. Unaudited Financial Results of the Company for the Half year ended September 30, 2026. Further, pursuant to Regulation 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the following: (i) Unaudited Financial Results for the half year ended September 30, 2026. (ii) Limited Review Report thereon, issued by the Statutory Auditors, M/s. A Y & Company, Chartered Accountants on the Unaudited Financial Results of the Company. The Board Meeting commenced at 01:30 PM and concluded at 02:00 PM. The above is for your information and record. Thanks & Regards For and on behalf of KK SHAH HOSPITALS LIMITED AMIT SHAH MANAGING DIRECTOR (DIN: 09119113) A Y & COMPANY 505, Fifth Floor, ARG Corporate Park Gopal Bari, Ajmer Road, Jaipur (Raj.) TEL NO. - +91-9649687300, Email: info@aycompany.co.in Limited Review Report on the Half Yearly Un-audited Standalone Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, As Amended Review Report The Board of Directors KK Shah Hospitals Limited 1. We have reviewed the accompanying statement of unaudited standalone financial results of KK Shah Hospitals Limited (the 'Company') for the Half year ended on September 30, 2026 (the "Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Regulation') as amended, read with SEBI Circular No. CIR/CFD/CMD1/44/2019 dated March 29, 2019 and Circular No. CIR/CFD/CMD1/80/2019 dated July 19, 2019 ('the Circular'). 2. The preparation of the Statement in accordance with the recognition and measurement principles laid down in Accounting Standard 25, "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, read with the Circular is the responsibility of the Company's management and has been approved by the Board of Directors of the Company. Our responsibility is to issue a report on these financial statements based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement of unaudited financial results, prepared in accordance with applicable Accounting Standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with circular no. CIR/CFD/FAC/62/2016 dated July 05, 2016 including the manner in which it is to be disclosed, or that it contains any material misstatement. For A Y & Company Chartered Accountants FRN: 020829C Arpit Gupta Partner M. No. 421544 UDIN – 26421544KPZNPW4482 Place: Ratlam Date: 29.10.2026 KK SHAH HOSPITALS LMITED CIN - U8S100MMP2022PL.C062 407 124.Katju Nagar, 3wstik APP., Website-www.shabhospitalratlam.con: Email: infoashahhospitalratlam.com Statement of lUnaudited Financial Results for the Half Year ended on September 30, 2026 Pursuant to regulation 33 of SEBI (L0DR) Regulation, 2015 Amount in Lakhs) Year to date flgures for Particalars Half Year ended on 30/09/2026 Hall Year ended on 31/03/2026 Hat 3 Y 0/e 0a 9r / e 20n 2d 5e d on Yea er n dto e dD a ot ne 3 f 0o /r 0 9H /a 2l 0f 2 y 6e ar Yea rr n dto e dD a ot ne 3 t 9o /r 0 9H /a 2l 0f 1 y 5r ar th 3e 1y /e 0ar 3 /e 2n Od 2e 6d on Unsndlted Audited Unaudted Unaudited Cnaadiud Audited INCONE FROM OPERATIONS R Ce hv ee rn Ie n or oo mm e Operations 553 2. .6 68 0 4 16 51 ..2 16 8| 481 3. .5 70 6 553 2. .6 68 0 4K 31 5 70 6 94 12 8 97 46 Total Revenue (1+) 556.28 476.45| 485.26 556.28 485.26 961.71 EXPENSES |Cost of Material Consumed 0.00 0.00 0.00 Purchase of Stock in Trade 0.00 0 00 EC rh na pn lg oc y en e Bn ev ne en ft io t n Ec xs p eo nf s F ei si shcd Goods,. Work-in-progrcss & Stock in Trede 1470 .. 20 20 | 1420 .. 00 70 1260 . 80 80 1470 .. 20 20 120 60 80 8 268 95 || DP en pa rn ec ce a tC io cs nt &Amortizalicn Expense 81.90 1 0 770. 60 70 900 .. 70 00 810 ., 90 10 99 0.0 70 0 160 8 0 30 7 |Cuier Expenses 312.79 307.40 289 312.79 289 84 5924 Total expenses (V) 541.92 527.13 507.42 541.9 S0742 1034.55 Profit before Exceptional & Extraordinary Items and tax (I-IV) 14.36 -50.68 -22.16| 14.36 -22.16| -72.84 Exceptional Items VI Profit before Extraordinary Items and tax (V-D) 14.36 -50.68 -22.16 14.36 -22.16 -72.84 VII Extraordnary Items Prufit befure lax (VII-VII) 14.36| -50.68 -22.16 14.36 -22.16 -72.84 Tar Expenses 1 Current Tax 0.00 -135 1.35 0.00 135 000 2 Deferred Tax -7.83 -19.5 8.97 -7.83 897 -10 57 2 Tax related to earlier year 0.00 0.00 0.00 0.00 Total Tax Expenses (N)) .783 -20 89 10.32 -7.83 1032 -10.57 XI Profit/(Loss) for the period from continuing operations (X-X) 22.19 -29.79 -32.48 22.19 -32.48| 62.27 XI Profi/(Loss) from discontinuing operation Tax Expernses of discontinuing operations XIV Profit/(Loss) from discontinuing operation after tar (XI-XIUI) XV Profit(Loss) for the Period (AI+XIV) 22.19 -29.79 32.48 22.19 -32.48 62.27 XVI Paid up Equity Share Capital 680.85 680.85 680.85 680.85 680.85 630.85 XVI Reserves & Surplus 620.66 598.47 628.26 620.66 628.26 598.47 XVM Eamings per equity share a)Basic 0.33 -0.44 -0 48 0.33 048 -091 2) Diluted 0.33 -0 44 -048 033 0 48 )91 Notes: The above Unaudted Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meeting held on October 29, 2026 2. The Statutory Auditors of the Company have carried out the Limited Review of thea bove financial results of the Company and bave expressed an unmodified opnion on these Results. 3. The Company is cnly having one reportable Segment i.e. Healthcare Services 4. There are no investor complaunts received'perndıng as on September 30, 2026 5. Previous ycar'ss period figurcs havc bccn rcgroupcdi reclassificd/ rcstatcd, wherever nocc3sary to confim to classification of current ycar/pcriod. For KK Shab Hospitals Linited Dr. Amit Shab Chairman Cum Managing Director DIN : 091191 13 Place : Ratlam Date : October 29. 2026 KK SHAH HOSPITALS LIMITED CIN - U8S100MP2022PLC062407 124, Katju Nagar, Swastik APP., Ratlam-457001, Mudhya Pradesh, Indiu Webs [Showing first 8,000 characters — download PDF for full document]